{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/UNBX"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"UNBX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"UNBX\",,,,,undefined,":{"symbol":"UNBX","market":"US","secType":"STK","nameCN":"Unity Biotechnology, Inc.","latestPrice":0.055,"timestamp":1754078400000,"preClose":0.1037,"halted":0,"volume":105055,"delay":15,"floatShares":0,"shares":17212172,"eps":0,"marketStatus":"Market Closed","change":-0.0487,"latestTime":"08-01 16:00:00 EDT Delay","open":0.103,"high":0.103,"low":0.0487,"amount":9397.318610000002,"amplitude":0.523626,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1754294400000},"marketStatusCode":7,"adr":0,"exchange":"PINK LIMITED","adjPreClose":0.1037,"volumeRatio":1.0708009867625317},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"UNBX\",,,,,undefined,":{"symbol":"UNBX","floatShares":0,"roa":"-38.89%","roe":"-231.27%","lyrEps":0,"volumeRatio":1.0708009867625317,"shares":17212172,"dividePrice":0,"high":0.103,"amplitude":0.523626,"preClose":0.1037,"low":0.0487,"week52Low":0.0487,"pbRate":"-4.62","week52High":0.1937,"institutionHeld":0,"latestPrice":0.055,"eps":0,"divideRate":0,"volume":105055,"delay":15,"open":0.103,"prevYearClose":0.2001,"prevWeekClose":0.1047,"prevMonthClose":0.1037,"prevQuarterClose":0.2001,"fiveDayClose":0.1047,"twentyDayClose":0.2001,"sixtyDayClose":0.2001},"@#url:\"https://hq.skytigris.cn/market/plate/belongs/UNBX\",params:#limit:6,delay:false,,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"UNBX\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2556164198","title":"UNITY Biotechnology Inc. Announces Date for Special Stockholders Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2556164198","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2556164198?lang=en_us&edition=fundamental","pubTime":"2025-08-01 21:01","pubTimestamp":1754053282,"startTime":"0","endTime":"0","summary":"UNITY Biotechnology Inc. has announced that a special meeting of stockholders will be held on September 18, 2025. The meeting will take place in a virtual format. During this meeting, stockholders will have the opportunity to vote on the proposed dissolution of the company.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. UNITY Biotechnology Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on August 01, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250801:nNDL3dYd5K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["UBX","BK4139","UNBX"],"gpt_icon":0},{"id":"2553263244","title":"UNITY Biotechnology Inc. Completes Sale of Series A Preferred Share to President Craig R. Jalbert for $1.00","url":"https://stock-news.laohu8.com/highlight/detail?id=2553263244","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553263244?lang=en_us&edition=fundamental","pubTime":"2025-07-23 04:06","pubTimestamp":1753214796,"startTime":"0","endTime":"0","summary":"On July 22, 2025, Unity Biotechnology, Inc. entered into a Purchase Agreement with Craig R. Jalbert, the company's President, Secretary, and sole director, to issue and sell one share of the newly designated Series A Preferred Stock for a purchase price of $1.00.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. UNITY Biotechnology Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on July 22, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250722:nNDL5kl7Q1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["UBX","UNBX","BK4139"],"gpt_icon":0},{"id":"2552431683","title":"UNITY Biotechnology Inc. Files Initial Statement of Beneficial Ownership; Craig R. Jalbert Named as Director, President, and Secretary","url":"https://stock-news.laohu8.com/highlight/detail?id=2552431683","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552431683?lang=en_us&edition=fundamental","pubTime":"2025-07-18 04:07","pubTimestamp":1752782828,"startTime":"0","endTime":"0","summary":"UNITY Biotechnology Inc. Files Initial Statement of Beneficial Ownership; Craig R. Jalbert Named as Director, President, and Secretary. UNITY Biotechnology Inc. has filed an initial statement of beneficial ownership with the SEC, identifying Craig R. Jalbert as the beneficial owner. Jalbert serves as a Director, President, and Secretary of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. UNITY Biotechnology Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on July 17, 2025, and is solely responsible for the information con","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250717:nNDL8BdlRX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["UBX","UNBX","BK4139"],"gpt_icon":0}],"pageSize":4,"totalPage":1,"pageCount":1,"totalSize":3,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/UNBX\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"UNBX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"UNBX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5,"buy":0,"hold":0.5,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0,"analysts":2,"updateTime":1748404800000}}}